Back to Show
PBS News Hour
What’s keeping biosimilar drugs from the U.S. market?
NewsHour looks at a revolutionary class of drugs called "biologics." Americans have been paying more for their benefits than patients in Europe or Asia some say, because the "generic" versions or "biosimilars" have not hit the U.S. market. Dr. Emily Senay looks into why there's a delay and when American consumers can expect discounts.
Support Provided By
Season
57:46
November 14, 2024 - PBS News Hour full episode
57:46
November 13, 2024 - PBS News Hour full episode
57:46
November 12, 2024 - PBS News Hour full episode
57:46
November 11, 2024 - PBS News Hour full episode
26:45
November 10, 2024 - PBS News Weekend full episode
26:45
November 9, 2024 - PBS News Weekend full episode
57:46
November 8, 2024 - PBS News Hour full episode
57:46
November 7, 2024 - PBS News Hour full episode
57:46
November 6, 2024 - PBS News Hour full episode
56:58
November 5, 2024 - PBS News Hour full episode
57:46
November 4, 2024 - PBS News Hour full episode
26:44
November 3, 2024 - PBS News Weekend full episode